This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Verhoef, K.
Right arrow Articles by Berkhout, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Verhoef, K.
Right arrow Articles by Berkhout, B.

 Previous Article  |  Next Article 

Journal of Virology, April 1999, p. 2781-2789, Vol. 73, No. 4
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.

A Second-Site Mutation That Restores Replication of a Tat-Defective Human Immunodeficiency Virus

Koen Verhoef and Ben Berkhout*

Department of Human Retrovirology, Academic Medical Center, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands

Received 21 September 1998/Accepted 14 December 1998

We previously constructed a large set of mutants of the human immunodeficiency virus type 1 (HIV-1) regulatory protein Tat with conservative amino acid substitutions in the activation domain. These Tat variants were analyzed in the context of the infectious virus, and several mutants were found to be defective for replication. In an attempt to obtain second-site suppressor mutations that could provide information on the Tat protein structure, some of the replication-impaired viruses were used as a parent for the isolation of revertant viruses with improved replication capacity. Sequence analysis of revertant viruses frequently revealed changes within the tat gene, most often first-site reversions either to the wild-type amino acid or to related amino acids that restore, at least partially, the Tat function and virus replication. Of 30 revertant cultures, we identified only one second-site suppressor mutation. The inactive Y26A mutant yielded the second-site suppressor mutation Y47N that partially restored trans-activation activity and virus replication. Surprisingly, when the suppressor mutation was introduced in the wild-type Tat background, it also improved the trans-activation function of this protein about twofold. We conclude that the gain of function measured for the Y47N change is not specific for the Y26A mutant, arguing against a direct interaction of Tat amino acids 26 and 47 in the three-dimensional fold of this protein. Other revertant viruses did not contain any additional Tat changes, and some viruses revealed putative second-site Tat mutations that did not significantly improve Tat function and virus replication. We reason that these mutations were introduced by chance through founder effects or by linkage to suppressor mutations elsewhere in the virus genome. In conclusion, the forced evolution of mutant HIV-1 genomes, which is an efficient approach for the analysis of RNA regulatory motifs, seems less suited for the analysis of the structure of this small transcription factor, although protein variants with interesting properties can be generated.

* Corresponding author. Mailing address: Department of Human Retrovirology, Academic Medical Center, University of Amsterdam, Meibergdreef 15, 1105 AZ Amsterdam, The Netherlands. Phone: 31-20-5664822. Fax: 31-20-6916531. E-mail: b.berkhout{at}amc.uva.nl.

Journal of Virology, April 1999, p. 2781-2789, Vol. 73, No. 4
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Hidalgo-Estevez, A. M., Gonzalez, E., Punzon, C., Fresno, M. (2006). Human immunodeficiency virus type 1 Tat increases cooperation between AP-1 and NFAT transcription factors in T cells. J. Gen. Virol. 87: 1603-1612 [Abstract] [Full Text]  
  • Ammosova, T., Jerebtsova, M., Beullens, M., Lesage, B., Jackson, A., Kashanchi, F., Southerland, W., Gordeuk, V. R., Bollen, M., Nekhai, S. (2005). Nuclear Targeting of Protein Phosphatase-1 by HIV-1 Tat Protein. J. Biol. Chem. 280: 36364-36371 [Abstract] [Full Text]  
  • Xie, B., Calabro, V., Wainberg, M. A., Frankel, A. D. (2004). Selection of TAR RNA-Binding Chameleon Peptides by Using a Retroviral Replication System. J. Virol. 78: 1456-1463 [Abstract] [Full Text]  
  • Ammosova, T., Jerebtsova, M., Beullens, M., Voloshin, Y., Ray, P. E., Kumar, A., Bollen, M., Nekhai, S. (2003). Nuclear Protein Phosphatase-1 Regulates HIV-1 Transcription. J. Biol. Chem. 278: 32189-32194 [Abstract] [Full Text]  
  • Reza, S. M., Shen, L.-M., Mukhopadhyay, R., Rosetti, M., Pe'ery, T., Mathews, M. B. (2003). A Naturally Occurring Substitution in Human Immunodeficiency Virus Tat Increases Expression of the Viral Genome. J. Virol. 77: 8602-8606 [Abstract] [Full Text]  
  • Xie, B., Wainberg, M. A., Frankel, A. D. (2003). Replication of Human Immunodeficiency Viruses Engineered with Heterologous Tat-Transactivation Response Element Interactions. J. Virol. 77: 1984-1991 [Abstract] [Full Text]  
  • Verhoef, K., Bilodeau, P. S., van Wamel, J. L. B., Kjems, J., Stoltzfus, C. M., Berkhout, B. (2001). Repair of a Rev-Minus Human Immunodeficiency Virus Type 1 Mutant by Activation of a Cryptic Splice Site. J. Virol. 75: 3495-3500 [Abstract] [Full Text]  
  • Verhoef, K., Marzio, G., Hillen, W., Bujard, H., Berkhout, B. (2001). Strict Control of Human Immunodeficiency Virus Type 1 Replication by a Genetic Switch: Tet for Tat. J. Virol. 75: 979-987 [Abstract] [Full Text]  
  • Jeang, K.-T., Xiao, H., Rich, E. A. (1999). Multifaceted Activities of the HIV-1 Transactivator of Transcription, Tat. J. Biol. Chem. 274: 28837-28840 [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»